J A Perez-Simon
Overview
Explore the profile of J A Perez-Simon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
688
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Suarez E, Boluda B, Lavilla E, Tormo M, Botella C, Gil C, et al.
Ann Hematol
. 2024 Jun;
103(8):2845-2851.
PMID: 38884787
FLT3-ITD and NPM1 mutations are key to defining the genetic risk profile of acute myeloid leukemia (AML). We aimed to assess the prognostic features of the FLT3-ITD and NPM1 mutations...
2.
Medrano M, Contreras M, Caballero-Velazquez T, Martinez L, Bejarano-Garcia J, Calderon-Ruiz R, et al.
Br J Cancer
. 2024 Mar;
130(9):1529-1541.
PMID: 38461169
Background: Several studies have described a potential anti-tumour effect of cannabinoids (CNB). CNB receptor 2 (CB2) is mostly present in hematopoietic stem cells (HSC). The present study evaluates the anti-leukaemic...
3.
Martinez-Maestre M, Castelo-Branco C, Calderon A, Espigado I, Perez-Simon J, Gonzalez-Cejudo C
Climacteric
. 2024 Feb;
27(3):275-281.
PMID: 38415712
Objective: Menopause and chronic graft-versus-host disease (cGvHD) are the leading causes of morbidity after allogeneic hematopoietic stem cell transplantation (alloHSCT). Genitalia are one of the target organs of cGvHD causing...
4.
Caballero-Velazquez T, Calderon-Cabrera C, Lopez-Corral L, Puig N, Marquez-Malaver F, Perez-Lopez E, et al.
Bone Marrow Transplant
. 2019 Sep;
55(2):419-430.
PMID: 31551517
This multicenter phase I trial was designed to evaluate the safety and efficacy of bortezomib (Bz) as part of both the conditioning regimen and the graft-versus-host disease (GvHD) prophylaxis. Patients...
5.
Rodriguez-Barbosa J, Ferreras M, Buhler L, Jones N, Schneider P, Perez-Simon J, et al.
MAbs
. 2018 Jul;
10(7):1030-1044.
PMID: 30036156
Natural killer (NK) cells are a population of innate type I lymphoid cells essential for early anti-viral responses and are known to modulate the course of humoral and cellular-mediated T...
6.
Molinos-Quintana A, Trujillo-Hacha P, Piruat J, Bejarano-Garcia J, Garcia-Guerrero E, Perez-Simon J, et al.
Invest New Drugs
. 2018 May;
37(1):17-26.
PMID: 29721755
The substance P/neurokinin-1 receptor system has been implicated in tumor cell proliferation. Neurokinin-1 receptor has been identified in different solid tumors but not frequently in hematopoietic malignant cells. We investigated...
7.
Prats-Martin C, Jimenez-Guerrero P, Morales-Camacho R, Caballero-Velazquez T, Vargas M, Perez O, et al.
Ann Hematol
. 2017 Nov;
97(3):533-535.
PMID: 29151134
No abstract available.
8.
Kharfan-Dabaja M, Parody R, Perkins J, Lopez-Godino O, Lopez-Corral L, Vazquez L, et al.
Bone Marrow Transplant
. 2016 Nov;
52(3):438-444.
PMID: 27819684
HLA-matched related or unrelated donors are not universally available. Consequently, patients can be offered hematopoietic stem cell transplantation (HSCT) from alternative donors, including mismatched unrelated donors (MMURD), known to cause...
9.
Parody R, Lopez-Corral L, Lopez-Godino O, Martinez C, Martino R, Solano C, et al.
Bone Marrow Transplant
. 2016 Jun;
51(11):1524-1526.
PMID: 27295268
No abstract available.
10.
Burillo-Sanz S, Vargas M, Morales-Camacho R, Caballero-Velazquez T, Sanchez J, Garcia-Lozano J, et al.
Hematol Oncol
. 2016 Mar;
35(4):894-899.
PMID: 26947932
Ring 21 is an unstable structural abnormality of chromosome 21 that can lead to RUNX1 gene amplification. We present a unique case with a carrier patient of a constitutional ring...